National Library of Medicine; Cancellation of Meeting, 70849 [2022-25317]

Download as PDF Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices lotter on DSK11XQN23PROD with NOTICES1 • 93.137 Community Programs to Improve Minority Health Grant Program • 93.217 Family Planning Services • 93.260 Family Planning Personnel Training • 93.297 Teenage Pregnancy Prevention Program • 98.343 Public Health Service Evaluation Funds • 93.344 Research, Monitoring and Outcomes Definitions for Vaccine Safety • 93.974 Family Planning Service Delivery Improvement Research Grants Full Assistance Listing descriptions are published and updated annually on https://sam.gov. Co-sponsors will work with OASH/GAM staff to jointly develop an event. Both OASH and the co-sponsor must contribute substantively to the development of the event. OASH Grants Workshops may be convened over one to three days; conducted virtually, in-person, or in a hybrid format (virtual and in-person). Depending on the workshop format and scope, a workshop may typically accommodate between 100 and 500 attendees. Co-sponsors can charge registration fees to recover costs associated with the events; however, co-sponsors may not set registration fees at an amount higher than necessary to recover related event expenses. Further, co-sponsors are solely responsible for collecting and handling any registration fees collected. Eligibility for Co-Sponsorship: The cosponsoring entity must have a demonstrated interest and experience in building capacity among potential grant applicants and grant recipients, particularly with respect to programs supported by GAM. The co-sponsoring entity must participate substantively in the co-sponsored activity, not just provide funding, logistical services, or other material support. Each potential co-sponsorship’s expression of interest shall describe: (1) The entity’s interest in building capacity among potential grant applicants and grant recipients, (2) The entity’s prior experience and current readiness to undertake the responsibilities described above, (3) The type of event(s) that the entity is interested in co-sponsoring with GAM, (4) Facilities and/or virtual platforms available for the event(s), and (5) Any current constraints with respect to dates or facilities. The type of event may be a special topic of mutual interest with one or VerDate Sep<11>2014 21:25 Nov 18, 2022 Jkt 259001 70849 more of the aforementioned GAM supported program offices and may be developed jointly. The expression of interest should be a bulleted outline, no more than two pages in length, single-spaced, and 11point font. An entity may submit an expression of interest individually or jointly with other entities describing their relative contributions. Evaluation Criteria: After engaging in exploratory discussions with potential co-sponsors that respond to this notice, the following considerations will be used by HHS officials, as appropriate and relevant, to select the co-sponsor(s): DEPARTMENT OF HEALTH AND HUMAN SERVICES • Qualifications and capability to fulfill co-sponsorship responsibilities • Suitability of the location of the proposed OASH Grants Workshops in terms of the overall geographical distribution of OASH Grants Workshops • Potential for reaching, generating, and engaging an adequate number of attendees who may be potential grant applicants and grant recipients • Availability and description of facilities and resources needed to support the OASH Grants Workshop • Availability of administrative support for the logistics of hosting such OASH Grants Workshops Dated: November 16, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. These duties will be outlined in a cosponsorship agreement with GAM and the sponsoring program office(s) that will set forth the details of the cosponsored activity, including the requirements that any fees collected by the co-sponsor shall be limited to the amount necessary to cover the cosponsor’s related event expenses. This co-sponsorship agreement does not represent an endorsement by HHS, OASH, GAM or its supported program office(s) of an individual co-sponsor’s policies, positions, or activities. Additionally, this agreement will not affect any determination concerning activities by the co-sponsors that are regulated by GAM’s grant-supporting offices. Dated: November 14, 2022. Scott J. Moore, Director, Grants and Acquisitions Management Division, Office of the Assistant Secretary for Health. [FR Doc. 2022–25259 Filed 11–18–22; 8:45 am] BILLING CODE 4150–28–P PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 National Institutes of Health National Library of Medicine; Cancellation of Meeting Notice is hereby given of the cancellation of the National Library of Medicine Special Emphasis Panel, March 16, 2023, 11 a.m. to 3 p.m., Virtual Meeting, which was published in the Federal Register on October 6, 2022, 87 FR 193 Page Number 60696. This notice is being amended to announce that the meeting is cancelled and will not be rescheduled. [FR Doc. 2022–25317 Filed 11–18–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA–DK–22–004 NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership. Date: December 16, 2022. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2 Democracy, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: John F. Connaughton, Ph.D., Chief, Scientific Review Branch, Review Branch, DEA, Niddk National Institutes of Health, Room 7007, 6707 E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Page 70849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25317]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Library of Medicine; Cancellation of Meeting

    Notice is hereby given of the cancellation of the National Library 
of Medicine Special Emphasis Panel, March 16, 2023, 11 a.m. to 3 p.m., 
Virtual Meeting, which was published in the Federal Register on October 
6, 2022, 87 FR 193 Page Number 60696.
    This notice is being amended to announce that the meeting is 
cancelled and will not be rescheduled.

    Dated: November 16, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-25317 Filed 11-18-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.